Rösner, T., Kretschmer, A., Lohse, S., Meyer, S., Jansen, J., Möginger, U., . . . Valerius, T. (2016). 440 - Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor. European Journal of Cancer, 69, S144. https://doi.org/10.1016/S0959-8049(16)33027-1
Chicago Style (17th ed.) CitationRösner, T., et al. "440 - Improvement of Pharmacokinetics and Myeloid Effector Cell Engagement in Vivo by Fc-engineering of IgA Antibody Against the Epidermal Growth Factor Receptor." European Journal of Cancer 69 (2016): S144. https://doi.org/10.1016/S0959-8049(16)33027-1.
MLA (9th ed.) CitationRösner, T., et al. "440 - Improvement of Pharmacokinetics and Myeloid Effector Cell Engagement in Vivo by Fc-engineering of IgA Antibody Against the Epidermal Growth Factor Receptor." European Journal of Cancer, vol. 69, 2016, p. S144, https://doi.org/10.1016/S0959-8049(16)33027-1.
